Skip to Content

93 7455 (Glipizide and metformin hydrochloride 2.5 mg / 250 mg)

Pill imprint 93 7455 has been identified as Glipizide and metformin hydrochloride 2.5 mg / 250 mg.

Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glipizide/metformin 2.5 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Glipizide and metformin hydrochloride 2.5 mg / 250 mg 93 7455
Glipizide and metformin hydrochloride 2.5 mg / 250 mg 93 7455 Front
Glipizide and metformin hydrochloride 2.5 mg / 250 mg 93 7455 Back
Glipizide and metformin hydrochloride 2.5 mg / 250 mg 93 7455
Glipizide and metformin hydrochloride
Imprint:
93 7455
Strength:
2.5 mg / 250 mg
Color:
Pink
Size:
13.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-7455
Inactive Ingredients:
corn starch
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
povidone k30
magnesium silicate
titanium dioxide
ferrosoferric oxide
ferric oxide red
ferric oxide yellow
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00591-3971 Watson Pharmaceuticals, Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide